Hims & Hers Health, Inc. has launched two new prescription offerings -- Topical Finasteride & Minoxidil Spray and Oral Spironolactone -- to provide women with more effective solutions to address hair loss, which 1 in 3 women -- roughly 30 million women in the US alone -- experience at some time in their lives. In recent years, medical experts have seen an increase in patients across the country suffering from stress-related hair loss. Internet searches alone for hair loss have increased by 8% in the 12 months since February 2021 – an average of more than 829,000 times a month in the US alone.

Hers has made the commitment to be the ally women need to help win the battle against hair loss with the introduction of two new prescription products: Topical Finasteride & Minoxidil Spray: The new topical spray combines 3% Finasteride and 6% Minoxidil, two clinically proven ingredients into a single, easy-to-use, no-mess spot treatment spray designed specifically for use by women. Oral Spironolactone: An easy once a day antiandrogen pill that is clinically proven to slow down shedding and regrow new hair for women experiencing hair loss. Hers offers a variety of hair care offerings, including stand-alone Minoxidil 5% foam and Minoxidil 2% topical solution hair regrowth treatments, as well as biotin gummies to support healthy hair, thickening shampoo and conditioner, repairing hair mask and a cleansing scalp scrub.

To further personalize the experience to the needs of individual consumers, Hers offers a simple hair care assessment tool, which provides a recommended hair care routine based on answers provided to a few hair related questions.